Scandinavian journal of trauma, resuscitation and emergency medicine
2026-06-03
Najlepsze praktyki dotyczące transfuzji krwi i produktów krwiopochodnych w protokole prehospitalarnym w przypadku krwotoków: konsensus z kanadyjskiego szczytu transfuzji prehospitalarnej 2025
Best practices on blood and blood products for a prehospital hemorrhage protocol: consensus from the 2025 Canadian prehospital transfusion summit.
Recenzja AI
Cel badania
Celem badania było opracowanie konsensusu dotyczącego najlepszych praktyk transfuzji krwi w warunkach prehospitalarnych w Kanadzie, uwzględniającego różnorodność regionalną i wyzwania logistyczne.
Metoda
Zastosowano proces konsensusu w formie strukturalnej dyskusji okrągłego stołu, w którym uczestniczyło ponad 50 ekspertów z różnych prowincji i systemów zdrowotnych.
Wyniki
Ustalono 12 kluczowych zaleceń dotyczących transfuzji krwi, w tym identyfikację czerwonych krwinek i kwasu traneksamowego jako podstawowych terapii oraz podkreślenie znaczenia logistyki produktów krwiopochodnych w obszarach wiejskich.
Znaczenie dla praktyki
Wyniki te mają istotne znaczenie dla polskich pracowników medycznych, ponieważ mogą przyczynić się do poprawy standardów opieki w sytuacjach nagłych, zwłaszcza w kontekście transfuzji krwi w warunkach prehospitalarnych.
Abstrakt oryginalny
BACKGROUND: Blood transfusion is increasingly recognized as a critical component of prehospital resuscitation. However, Canada's vast geography, environmental extremes, and regional variation in health systems present unique challenges to standardized implementation of prehospital hemorrhage protocols (PHPs). The 2025 Canadian Prehospital Transfusion Summit (CPTS), convened by the Canadian Prehospital and Transport Transfusion (CAN-PATT) network, sought to develop consensus-driven best practices for prehospital transfusion strategies across diverse transport environments. METHODS: A structured roundtable consensus process was held at CPTS 2025, bringing together over 50 subject matter experts from eight provinces, six different services/systems and a variety of operational roles to discuss the past, present and future direction of out-of-hospital blood transfusion in Canada. Key domains included: activation criteria, prioritization of blood components and adjuncts, product logistics, and rural/remote applicability. Recommendations were synthesized through iterative discussion, evidence review, and thematic analysis. Each recommendation was then voted upon until consensus was reached through all participants. RESULTS: Consensus was reached on core components of a national PHP. Red blood cells and tranexamic acid were identified as foundational therapies. Freeze-dried plasma and whole blood offer logistical and clinical advantages, particularly in rural and remote areas, while fibrinogen concentrate and prothrombin complex concentrate are valuable adjuncts when plasma is unavailable. Calcium supplementation and active hypothermia prevention were emphasized as essential. Barriers to implementation included short product shelf-life, storage infrastructure, and regulatory constraints. The group recommended development of a standardized Canadian prehospital transfusion dataset and national data registry. CONCLUSIONS: The panel produced 12 consensus statements based on the available evidence and expert opinion including activation criteria, prioritization of blood products and adjuncts, product logistics, and rural/remote applicability. These consensus statements establish the basis for safe and effective PHP practices in Canada.
Źródło
Scandinavian journal of trauma, resuscitation and emergency medicine
2026-06-03
DOI: 10.1186/s13049-026-01630-4
PMID: 42237186
PubMed Pełny tekst